» Articles » PMID: 36193076

Epidermal Growth Factor Receptor Inhibition Is Protective in Hyperoxia-Induced Lung Injury

Abstract

Aims: Studies have linked severe hyperoxia, or prolonged exposure to very high oxygen levels, with worse clinical outcomes. This study investigated the role of epidermal growth factor receptor (EGFR) in hyperoxia-induced lung injury at very high oxygen levels (>95%).

Results: Effects of severe hyperoxia (100% oxygen) were studied in mice with genetically inhibited EGFR and wild-type littermates. Despite the established role of EGFR in lung repair, EGFR inhibition led to improved survival and reduced acute lung injury, which prompted an investigation into this protective mechanism. Endothelial EGFR genetic knockout did not confer protection. EGFR inhibition led to decreased levels of cleaved caspase-3 and poly (ADP-ribosyl) polymerase (PARP) and decreased terminal dUTP nick end labeling- (TUNEL-) positive staining in alveolar epithelial cells and reduced ERK activation, which suggested reduced apoptosis . EGFR inhibition decreased hyperoxia (95%)-induced apoptosis and ERK in murine alveolar epithelial cells , and CRISPR-mediated EGFR deletion reduced hyperoxia-induced apoptosis and ERK in human alveolar epithelial cells . . This work defines a protective role of EGFR inhibition to decrease apoptosis in lung injury induced by 100% oxygen. This further characterizes the complex role of EGFR in acute lung injury and outlines a novel hyperoxia-induced cell death pathway that warrants further study.

Conclusion: In conditions of severe hyperoxia (>95% for >24 h), EGFR inhibition led to improved survival, decreased lung injury, and reduced cell death. These findings further elucidate the complex role of EGFR in acute lung injury.

Citing Articles

Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale University.

Wurstle S, Lee A, Kortright K, Winzig F, An W, Stanley G Sci Rep. 2024; 14(1):2657.

PMID: 38302552 PMC: 10834462. DOI: 10.1038/s41598-024-52192-3.

References
1.
Cantley L . The phosphoinositide 3-kinase pathway. Science. 2002; 296(5573):1655-7. DOI: 10.1126/science.296.5573.1655. View

2.
Zhang Y, Jiang G, Sauler M, Lee P . Lung endothelial HO-1 targeting in vivo using lentiviral miRNA regulates apoptosis and autophagy during oxidant injury. FASEB J. 2013; 27(10):4041-58. PMC: 4046184. DOI: 10.1096/fj.13-231225. View

3.
Schreier B, Stern C, Dubourg V, Nolze A, Rabe S, Mildenberger S . Endothelial epidermal growth factor receptor is of minor importance for vascular and renal function and obesity-induced dysfunction in mice. Sci Rep. 2021; 11(1):7269. PMC: 8012653. DOI: 10.1038/s41598-021-86587-3. View

4.
Finigan J, Downey G, Kern J . Human epidermal growth factor receptor signaling in acute lung injury. Am J Respir Cell Mol Biol. 2012; 47(4):395-404. PMC: 3488630. DOI: 10.1165/rcmb.2012-0100TR. View

5.
Lee D, Cross S, Strunk K, Morgan J, Bailey C, Jackson I . Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor. Mamm Genome. 2004; 15(7):525-36. DOI: 10.1007/s00335-004-2384-2. View